Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review.

By C. Friedman, T. Proverbs-Singh, M. Postow. JAMA Oncology, 2016

758 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology, Surgery

View Paper: https://www.semanticscholar.org/paper/78abec78ad05ad6f9c74ba303fb0cb50598c096b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. J. Wolchok

Citations in the corpus

• Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline (2018, background): “Hypoxia may occur and progress rapidly, leading to respiratory failure.(40,52) Ground-glass opacities or patchy nodular infiltrates, predominantly in the lower lobes, are common manifestations on chest imaging.”